Literature DB >> 19132802

Determinants of under-reporting of adverse drug reactions: a systematic review.

Elena Lopez-Gonzalez1, Maria T Herdeiro, Adolfo Figueiras.   

Abstract

A voluntary reporting system of adverse drug reactions (ADRs) is fundamental to drug safety surveillance but under-reporting is its major limitation. This bibliographic review sought to assess the influence of personal and professional characteristics on ADR reporting and to identify knowledge and attitudes associated with ADR reporting. A systematic review was conducted using the MEDLINE and EMBASE databases. We included papers that were published in English, French and Spanish, and covered a study population made up of health professionals. In each case, the following data were extracted: study population; workplace; study type; sample size; type of questionnaire; type of scale for measuring knowledge; response rate; personal and professional factors; and knowledge and attitudes (based on Inman's 'seven deadly sins') associated with reporting. Based on a search of computerized databases, we identified a total of 657 papers in MEDLINE and 973 in EMBASE. In all, the review covered 45 papers that fulfilled the inclusion criteria. Medical specialty was the professional characteristic most closely associated with under-reporting in 76% of studies involving physicians. Other factors associated with under-reporting were ignorance (only severe ADRs need to be reported) in 95%; diffidence (fear of appearing ridiculous for reporting merely suspected ADRs) in 72%; lethargy (an amalgam of procrastination, lack of interest or time to find a report card, and other excuses) in 77%; indifference (the one case that an individual doctor might see could not contribute to medical knowledge) and insecurity (it is nearly impossible to determine whether or not a drug is responsible for a particular adverse reaction) in 67%; and complacency (only safe drugs are allowed on the market) in 47% of studies. While personal and professional factors display a weak influence, the knowledge and attitudes of health professionals appear to be strongly related with reporting in a high proportion of studies. This result may have important implications in terms of public health, if knowledge and attitudes are viewed as potentially modifiable factors.

Mesh:

Year:  2009        PMID: 19132802     DOI: 10.2165/00002018-200932010-00002

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  51 in total

1.  Physicians' attitudes towards voluntary reporting of adverse drug events.

Authors:  A Figueiras; F Tato; J Fontaiñas; B Takkouche; J J Gestal-Otero
Journal:  J Eval Clin Pract       Date:  2001-11       Impact factor: 2.431

2.  Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital.

Authors:  A Vallano; G Cereza; C Pedròs; A Agustí; I Danés; C Aguilera; J M Arnau
Journal:  Br J Clin Pharmacol       Date:  2005-12       Impact factor: 4.335

Review 3.  Factors that influence spontaneous reporting of adverse drug reactions: a model centralized in the medical professional.

Authors:  María T Herdeiro; Jorge Polonia; Juan J Gestal-Otero; Adolfo Figueiras
Journal:  J Eval Clin Pract       Date:  2004-11       Impact factor: 2.431

4.  Adverse drug reactions reporting at a referral hospital in Zimbabwe.

Authors:  S Khoza; I Madungwe; P Nyambayo; J Mthethwa; O Chikuni
Journal:  Cent Afr J Med       Date:  2004 Nov-Dec

5.  Is there still a role for spontaneous reporting of adverse drug reactions?

Authors:  Joel Lexchin
Journal:  CMAJ       Date:  2006-01-17       Impact factor: 8.262

6.  Adverse drug reactions leading to hospital admission.

Authors:  L Ibáñez; J R Laporte; X Carné
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

7.  Attitudes to adverse drug reaction reporting.

Authors:  W H Inman
Journal:  Br J Clin Pharmacol       Date:  1996-05       Impact factor: 4.335

8.  Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project.

Authors:  H D Scott; A Thacher-Renshaw; S E Rosenbaum; W J Waters; M Green; L G Andrews; G A Faich
Journal:  JAMA       Date:  1990-04-04       Impact factor: 56.272

9.  Pharmacy-coordinated program that encourages physician reporting of adverse drug reactions.

Authors:  G W Gilroy; M J Scollins; C A Gay; D J Harry; D F Giannuzzi
Journal:  Am J Hosp Pharm       Date:  1990-06

10.  [Adverse drug reactions and a program of voluntary notification: an opinion survey of primary care physicians].

Authors:  G Serrano Cózar; C Esteban Calvo; J A Gijón Porta; I Vaquero Turiño; M I Vázquez Burgos; C Ibáñez Ruiz; J Frías Iniesta
Journal:  Aten Primaria       Date:  1997-04-15       Impact factor: 1.137

View more
  169 in total

1.  Adverse drug reactions: analysis of spontaneous reporting system in Europe in 2007-2009.

Authors:  Jindrich Srba; Veronika Descikova; Jiri Vlcek
Journal:  Eur J Clin Pharmacol       Date:  2012-02-01       Impact factor: 2.953

2.  Workshop- and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal.

Authors:  Maria Teresa Herdeiro; Inês Ribeiro-Vaz; Mónica Ferreira; Jorge Polónia; Amílcar Falcão; Adolfo Figueiras
Journal:  Drug Saf       Date:  2012-08-01       Impact factor: 5.606

3.  Effect of an educational intervention to improve adverse drug reaction reporting in physicians: a cluster randomized controlled trial.

Authors:  Elena Lopez-Gonzalez; Maria T Herdeiro; María Piñeiro-Lamas; Adolfo Figueiras
Journal:  Drug Saf       Date:  2015-02       Impact factor: 5.606

4.  Knowledge, practices and attitudes towards adverse drug reaction reporting by private practitioners from klang valley in malaysia.

Authors:  Renu Agarwal; Aqil Mohammad Daher; Nafeeza Mohd Ismail
Journal:  Malays J Med Sci       Date:  2013-03

5.  Innovative Digital Tools and Surveillance Systems for the Timely Detection of Adverse Events at the Point of Care: A Proof-of-Concept Study.

Authors:  Christian Hoppe; Patrick Obermeier; Susann Muehlhans; Maren Alchikh; Lea Seeber; Franziska Tief; Katharina Karsch; Xi Chen; Sindy Boettcher; Sabine Diedrich; Tim Conrad; Bron Kisler; Barbara Rath
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

6.  Serious adverse drug events related to non-investigational drugs in academic clinical trials: another source of safety data for risk assessment?

Authors:  Pascale Olivier; Anne Gimbert; Anne-Laurène Colin; Francesco Salvo; Madlyne Becker; Valérie Marty; Jean-Louis Montastruc; Nadine Petitpain
Journal:  Br J Clin Pharmacol       Date:  2016-07-13       Impact factor: 4.335

7.  Influence of attitudes on pharmacists' intention to report serious adverse drug events to the Food and Drug Administration.

Authors:  Paul Gavaza; Carolyn M Brown; Kenneth A Lawson; Karen L Rascati; James P Wilson; Mary Steinhardt
Journal:  Br J Clin Pharmacol       Date:  2011-07       Impact factor: 4.335

8.  Pharmacy students' knowledge and perceptions about pharmacovigilance in Malaysian public universities.

Authors:  Ramadan Mohamed Elkalmi; Mohamed Azmi Hassali; Mohamed Izham M Ibrahim; Riyanto T Widodo; Qais M A Efan; Muhammad Abdul Hadi
Journal:  Am J Pharm Educ       Date:  2011-06-10       Impact factor: 2.047

9.  Effectiveness of pharmacovigilance training of general practitioners: a retrospective cohort study in the Netherlands comparing two methods.

Authors:  Roald Gerritsen; Hans Faddegon; Fred Dijkers; Kees van Grootheest; Eugène van Puijenbroek
Journal:  Drug Saf       Date:  2011-09-01       Impact factor: 5.606

10.  The fatal love of forms.

Authors:  Bruce Hugman
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.